急非淋白血病aml-(m0~m7)，各代表什么意思? 血液科史淑荣 临床上，根据白血病细胞不成熟的程度和白血病的自然病程有急性和慢性两大类，而急性白血病又有急性淋巴细胞白血病和 急性髓细胞白血病 (又称“急非淋”)，而急非淋的分型有M0，M1，M2，M3，M4，M5，M6 ...

Acute myeloid leukemia (AML), on the other hand, does not usually form tumors. It generally is widespread throughout the bone marrow and bloodstream. In some cases, it has spread to other organs, such as the liver and spleen, as well.

aml的分型. 根据临床上常用的白血病分型标准—— fab标准 ，aml可进一步分为m0~m7八种亚型（见下图），如 急性早幼粒细胞白血病 就是aml的一种亚型——m3型，通常简称为apl。之所以对aml进行分型，是因为分型对评估预后，制定治疗方案至关重要。 aml分型

急性髓系白血病(aml)是髓系造血干/祖细胞恶性疾病，以骨髓和外周血中原始和幼稚髓性细胞异常增生为特征。 急髓白血病在 FAB分型 标准中分为八个亚型：

Minimally differentiated acute myeloblastic leukemia is a subtype of AML. It is classified as M0 by FAB. It represents 2–3% of all cases of AML. [1] Although minimally differentiated AML was recognized earlier, criteria for FAB M0 were developed in 1987. [2]

M0 is an acute leukemia with no evidence of myeloid differentiation by light mocroscopy. Immunophenotyping studies are essential in all cases to distinguish this disease from acute lymphoblastic leukemia ( ALL ).

By definition, AML-M0 includes acute leukemias which do not fit morphological and cytochemical criteria for the diagnosis of AML, and for which myeloid lineage assignment can be made by immunological assay showing positivity for MPO, CD13, …

2006年12月7日 · Minimally differentiated acute myeloid leukemia (AML-M0) is a rare AML subtype in both children and adults. 1–8 Since its recognition as a distinct entity in 1987, 9 the French-American-British (FAB) Cooperative Group has proposed that the criteria for a diagnosis of AML-M0 consist of the presence of less than 3% myeloperoxidase (MPO)– and ...

By definition, AML-M0 includes acute leukemias which do not fit morphological and cytochemical criteria for the diagnosis of AML, and for which myeloid lineage assignment can be made by immunological assay showing positivity for MPO, CD13, …

Acute myelogenous leukemia with minimal differentiation (AML-M0) is a rare subtype of acute leukemia in which blasts fail to show morphologic differentiation and conventional cytochemical stains and myeloid markers are negative.